Fresenius Medical (Germany) Today

FME Stock  EUR 41.35  0.01  0.02%   

Performance

12 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 9

 
High
 
Low
Low
Fresenius Medical is trading at 41.35 as of the 2nd of December 2024. This is a 0.02% down since the beginning of the trading day. The stock's lowest day price was 41.35. Fresenius Medical has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Fresenius Medical Care are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. FRESEN MED is traded on Frankfurt Stock Exchange in Germany.. The company has 293.41 M outstanding shares. More on Fresenius Medical Care

Moving together with Fresenius Stock

  0.97FMEA Fresenius Medical CarePairCorr

Moving against Fresenius Stock

  0.71SSU Samsung ElectronicsPairCorr
  0.69SSU Samsung ElectronicsPairCorr
  0.67PQ9 PT Bank MandiriPairCorr
  0.63TCID Telkom Indonesia TbkPairCorr
  0.62SSUN Samsung ElectronicsPairCorr
  0.62BH HCA HealthcarePairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Fresenius Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fresenius Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fresenius Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationMedical Care, Healthcare (View all Sectors)
Fresenius Medical Care (FME) is traded on Frankfurt Exchange in Germany and employs 128,044 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresenius Medical's market, we take the total number of its shares issued and multiply it by Fresenius Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fresenius Medical Care classifies itself under Healthcare sector and is part of Medical Care industry. The entity has 293.41 M outstanding shares. Fresenius Medical Care has accumulated about 922 M in cash with 2.17 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04.
Check Fresenius Medical Probability Of Bankruptcy
Ownership Allocation
Fresenius Medical holds a total of 293.41 Million outstanding shares. Fresenius Medical Care retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fresenius Ownership Details

Fresenius Medical Care Risk Profiles

Although Fresenius Medical's alpha and beta are two of the key measurements used to evaluate Fresenius Medical's performance over the market, the standard measures of volatility play an important role as well.

Fresenius Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Fresenius Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Fresenius Medical Corporate Management

Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dominik HegerStrategic RelationsProfile
Helen GizaChief CEOProfile
Roberto FusteEx StrategyProfile
William ValleManagement AGProfile
Nwamaka MDHead OperationsProfile
Katarzyna MazurHofsabManagement AGProfile
Borries MullerVP CommunicationsProfile

Additional Information and Resources on Investing in Fresenius Stock

When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.